ANTARES PHARMA INC (ATRS) Stock Income Statement
NASDAQ:ATRS • US0366421065
5.59
0 (0%)
At close: May 23, 2022
5.59
0 (0%)
After Hours: 5/23/2022, 8:12:09 PM
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 183.98M | 149.60M | 123.90M | 63.60M | 54.50M | |||
| Cost Of Goods | 68.28M | 63.10M | 50.50M | 31.10M | 27.50M | |||
| Gross Profit | 115.70M | 86.50M | 73.40M | 32.50M | 27.00M | |||
| Operating Expenses | 88.36M | 72.90M | 72.40M | 49.10M | 43.50M | |||
| Research and Development | 14.50M | 10.10M | 10.60M | 12.30M | 13.10M | |||
| Selling, General, and Administrative Expenses | 72.82M | 62.50M | 61.40M | 36.20M | 29.80M | |||
| Operating Income | 27.34M | 13.60M | 1.00M | -16.60M | -16.50M | |||
| Interest Income/Expense | -3.61M | -3.80M | -3.50M | -2.70M | -1.40M | |||
| Other Income/Expense | -50.00K | 100.00K | 500.00K | 300.00K | 300.00K | |||
| Income Before Taxes | 62.27M | 9.90M | -2.00M | -6.50M | -16.70M | |||
| Income Tax | 15.98M | -46.30M | 0.00 | 0.00 | 0.00 | |||
| Net Income | 46.29M | 56.20M | -2.00M | -6.50M | -16.70M | |||
| EBITDA | 31.24M | 16.23M | 3.56M | -13.88M | -14.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.26 | 0.33 | -0.01 | -0.04 | -0.11 | |||
| Non GAAP EPS | 0.27 | 0.06 | 0.00 | -0.04 | -0.10 | |||
| Statistics | ||||||||
| Gross Profit Margin | 62.89% | 57.82% | 59.24% | 51.10% | 49.54% | |||
| Profit Margin | 25.16% | 37.57% | -1.61% | -10.22% | -30.64% | |||
| Operating Profit Margin | 14.86% | 9.09% | 0.81% | -26.10% | -30.28% | |||
All data in USD